Cargando…

Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function

Although pleuroscopy is considered a safe and well tolerated procedure with a low complication rate, it requires the administration of procedural sedation and analgesia. The purpose of this study was to assess the effects of dexmedetomidine administration on oxygenation and respiratory function in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostroglou, Andreas, Kapetanakis, Emmanouil I., Matsota, Paraskevi, Tomos, Periklis, Kostopanagiotou, Konstantinos, Tomos, Ioannis, Siristatidis, Charalampos, Papapanou, Michail, Sidiropoulou, Tatiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396832/
https://www.ncbi.nlm.nih.gov/pubmed/34441805
http://dx.doi.org/10.3390/jcm10163510
_version_ 1783744465316347904
author Kostroglou, Andreas
Kapetanakis, Emmanouil I.
Matsota, Paraskevi
Tomos, Periklis
Kostopanagiotou, Konstantinos
Tomos, Ioannis
Siristatidis, Charalampos
Papapanou, Michail
Sidiropoulou, Tatiana
author_facet Kostroglou, Andreas
Kapetanakis, Emmanouil I.
Matsota, Paraskevi
Tomos, Periklis
Kostopanagiotou, Konstantinos
Tomos, Ioannis
Siristatidis, Charalampos
Papapanou, Michail
Sidiropoulou, Tatiana
author_sort Kostroglou, Andreas
collection PubMed
description Although pleuroscopy is considered a safe and well tolerated procedure with a low complication rate, it requires the administration of procedural sedation and analgesia. The purpose of this study was to assess the effects of dexmedetomidine administration on oxygenation and respiratory function in patients undergoing diagnostic or therapeutic pleuroscopy. Through a prospective, single center, cohort study, we studied 55 patients receiving either a dexmedetomidine intravenous infusion supplemented by midazolam/fentanyl (Group DEX + MZ/F) or a conventional sedation protocol with midazolam/fentanyl (Group MZ/F). Our primary outcome was the changes in lung gas exchange (PaO(2)/FiO(2) ratio) obtained at baseline and at predetermined end points, while changes in respiratory mechanics (FEV1, FVC and the ratio FEV1/FVC) and PaCO(2) levels, drug consumption, time to recover from sedation and adverse events were our secondary endpoints (NCT03597828). We found a lower postoperative decrease in FEV1 volumes in Group DEX + MZ/F compared to Group MZ/F (p = 0.039), while FVC, FEV1/FVC and gas exchange values did not differ between groups. We also found a significant reduction in midazolam (p < 0.001) and fentanyl consumption (p < 0.001), along with a more rapid recovery of alertness postprocedure in Group DEX + MZ/F compared to Group MZ/F (p = 0.003), while pain scores during the postoperative period, favored the Group DEX + MZ/F (p = 0.020). In conclusion, the use of intravenous dexmedetomidine during pleuroscopy is associated with a smaller decrease in FEV1, reduction of the consumption of supplementary sedatives and analgesics and quicker awakening of patients postoperatively, when compared to midazolam/fentanyl. Therefore, dexmedetomidine administration may provide clinically significant benefits in terms of lung mechanics and faster recovery of patients undergoing pleuroscopy.
format Online
Article
Text
id pubmed-8396832
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83968322021-08-28 Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function Kostroglou, Andreas Kapetanakis, Emmanouil I. Matsota, Paraskevi Tomos, Periklis Kostopanagiotou, Konstantinos Tomos, Ioannis Siristatidis, Charalampos Papapanou, Michail Sidiropoulou, Tatiana J Clin Med Article Although pleuroscopy is considered a safe and well tolerated procedure with a low complication rate, it requires the administration of procedural sedation and analgesia. The purpose of this study was to assess the effects of dexmedetomidine administration on oxygenation and respiratory function in patients undergoing diagnostic or therapeutic pleuroscopy. Through a prospective, single center, cohort study, we studied 55 patients receiving either a dexmedetomidine intravenous infusion supplemented by midazolam/fentanyl (Group DEX + MZ/F) or a conventional sedation protocol with midazolam/fentanyl (Group MZ/F). Our primary outcome was the changes in lung gas exchange (PaO(2)/FiO(2) ratio) obtained at baseline and at predetermined end points, while changes in respiratory mechanics (FEV1, FVC and the ratio FEV1/FVC) and PaCO(2) levels, drug consumption, time to recover from sedation and adverse events were our secondary endpoints (NCT03597828). We found a lower postoperative decrease in FEV1 volumes in Group DEX + MZ/F compared to Group MZ/F (p = 0.039), while FVC, FEV1/FVC and gas exchange values did not differ between groups. We also found a significant reduction in midazolam (p < 0.001) and fentanyl consumption (p < 0.001), along with a more rapid recovery of alertness postprocedure in Group DEX + MZ/F compared to Group MZ/F (p = 0.003), while pain scores during the postoperative period, favored the Group DEX + MZ/F (p = 0.020). In conclusion, the use of intravenous dexmedetomidine during pleuroscopy is associated with a smaller decrease in FEV1, reduction of the consumption of supplementary sedatives and analgesics and quicker awakening of patients postoperatively, when compared to midazolam/fentanyl. Therefore, dexmedetomidine administration may provide clinically significant benefits in terms of lung mechanics and faster recovery of patients undergoing pleuroscopy. MDPI 2021-08-09 /pmc/articles/PMC8396832/ /pubmed/34441805 http://dx.doi.org/10.3390/jcm10163510 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kostroglou, Andreas
Kapetanakis, Emmanouil I.
Matsota, Paraskevi
Tomos, Periklis
Kostopanagiotou, Konstantinos
Tomos, Ioannis
Siristatidis, Charalampos
Papapanou, Michail
Sidiropoulou, Tatiana
Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
title Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
title_full Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
title_fullStr Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
title_full_unstemmed Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
title_short Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
title_sort monitored anesthesia care with dexmedetomidine supplemented by midazolam/fentanyl versus midazolam/fentanyl alone in patients undergoing pleuroscopy: effect on oxygenation and respiratory function
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396832/
https://www.ncbi.nlm.nih.gov/pubmed/34441805
http://dx.doi.org/10.3390/jcm10163510
work_keys_str_mv AT kostroglouandreas monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT kapetanakisemmanouili monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT matsotaparaskevi monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT tomosperiklis monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT kostopanagiotoukonstantinos monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT tomosioannis monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT siristatidischaralampos monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT papapanoumichail monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction
AT sidiropouloutatiana monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction